HPV16 E6、E7多表位DNA疫苗的构建及免疫效果评估  

Evaluations of Immunogenicity and Efficacy of A Novel HPV16 E6 and E7 Multi-epitope DNA Vaccine

作　　者：崔湘杰 陶玉芬[1] 朱兰芳 姚宇峰[1] 史荔[1] CUI Xiangjie;TAO Yufen;ZHU Lanfang;YAO Yufeng;SHI Li(Institute of Medical Biology,Chinese Academy of Medical Sciences&Peking Union Medical College,Kunming Yunnan 650118,China)

机构地区：[1]中国医学科学院&北京协和医学院医学生物学研究所,云南昆明650118

出　　处：《昆明医科大学学报》2024年第5期16-22,共7页Journal of Kunming Medical University

基　　金：中国医学科学院医学与健康科技创新工程基金资助项目(2021-I2M-1-004);云南省重大科技专项基金资助项目(202002AA100009)。

摘　　要：目的构建和评价HPV16 E6、E7多表位DNA疫苗诱导的特异性CTL细胞应答及其对肿瘤生长的干预作用,从而揭示其作为候选HPV治疗性疫苗的潜能。方法首先通过IEDB网站中的MHC I Processing Predictions和MHC I Binding Predictions方法,分别预测人类HLA-A^(*)02:01、HLA-A^(*)11:01、HLA-A^(*)24:02和C57BL/6小鼠H-2b的限制性CTL表位,然后根据评分以及ELISPOT实验筛选出二者共同呈递的CTL表位,并将其构建成多表位DNA疫苗(pVAX1-10P)。从预防性和治疗性二个方面研究pVAX1-10P对小鼠移植TC-1异位癌的免疫干预作用,流式细胞术检测特异性CTL应答。结果获得10条可被人与鼠MHC分子共呈递的CTL表位,ELISPOT结果表明这10条CTL表位均能诱导小鼠淋巴细胞产生特异性免疫应答;由此构建的多表位DNA疫苗pVAX1-10P无论在预防性实验还是治疗性实验中,均能诱导特异性的细胞免疫并抑制肿瘤的生长。结论构建的HPV16 E6、E7多表位DNA疫苗pVAX1-10P能够诱导特异性CTL应答,显著抑制肿瘤生长,有望作为候选HPV治疗性DNA疫苗。Objective To construct and evaluate the specific CTL cell response induced by HPV16 E6 and E7 multi epitope DNA vaccines and their intervention effects on tumor growth so as to reveal their potential as candidate HPV therapeutic vaccines.Methods The CTL epitopes of human HLA-A^(*)02:01,HLA-A^(*)11:01,HLAA^(*)24:02 restriction and C57BL/6 mouse H-2b restriction were predicted by the MHC-I processing and MHC-I binding methods in the IEDB website,and then screened for co-presentation of both based on scoring as well as ELISPOT experiment.The predicted CTL epitopes obtained were constructed into a multi-epitope DNA vaccine(pVAX1-10P),and the immunological interventions were performed in the mice transplanted with TC-1 tumour cells from prophylactic and therapeutic strategies respectively,and the ability of pVAX1-10P to induce specific CTL responses was assessed by flow cytometry.Results Prediction and screening yielded 10 CTL antigenic epitopes co-presented by human and murine MHC molecules.ELISPOT results showed that each peptide in the experimental group induced the specific immune responses in mouse lymphocytes.The constructed multi-epitope DNA vaccine,pVAX1-10P,induced the specific cellular immunity and significantly inhibited the tumour growth in both prophylactic and therapeutic experiments.Conclusion The constructed HPV16 E6 and E7 multi-epitope DNA vaccine,pVAX1-10P can induce specific CTL response and inhibit the tumour growth,which is expected as a promising candidate of HPV therapeutic DNA vaccine.

关 键 词：宫颈癌 人乳头瘤病毒16 E6蛋白 E7蛋白 多表位DNA疫苗 

分 类 号：R737.33[医药卫生—肿瘤]